Venous sinus stenting for idiopathic intracranial hypertension patients with functioning ventriculoperitoneal shunts: A case series

Kareem El Naamani; Rawad Abbas; Stavropoula I Tjoumakaris; Nabeel A Herial; Hekmat Zarzour; Richard F Schmidt; Robert H Rosenwasser; Pascal M Jabbour; James Evans; M Reid Gooch

doi:10.1016/j.clineuro.2023.107894

Venous sinus stenting for idiopathic intracranial hypertension patients with functioning ventriculoperitoneal shunts: A case series

Clin Neurol Neurosurg. 2023 Oct:233:107894. doi: 10.1016/j.clineuro.2023.107894. Epub 2023 Jul 13.

Affiliations

¹ Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
² Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA. Electronic address: reid.gooch@jefferson.edu.

PMID: 37499303
DOI: 10.1016/j.clineuro.2023.107894

Abstract

Idiopathic intracranial hypertension (IIH) is a disease defined by increased intracranial pressure and associated with a variety of symptoms ranging from headaches to tinnitus. Ventricular peritoneal shunting has been the mainstay treatment for patients with IIH. Although VPS's have shown efficacy in treating IIH, some patients complain of refractory symptoms even with functioning VPS's. Venus stenting has emerged as a new technique for treating these refractory symptoms. Despite the scarce literature pertaining its efficacy and safety profile, several small studies have shown promising results. In this case series, four patients with IIH complained of refractory symptoms despite functioning VPS's and were treated with venous stenting.

Keywords: Idiopathic intracranial hypertension; Venous sinus stenting; Ventriculoperitoneal shunt.